Emergency ACIP Meeting TODAY (4/14) from 1:30-4:30p.m. Regarding the J & J COVID-19 Vaccine

Good Morning Immunization Providers,

Many of you heard yesterday that the Centers for Disease Control and Prevention (CDC) along with the U.S. Food and Drug Administration (FDA) released a joint statement regarding a rare and severe type of blood clot in individuals after receiving the Janssen (Johnson & Johnson) COVID-19 vaccine. At this time, these adverse events appear to be extremely rare and have not been causally associated to the vaccine. Please see the attached statement that went out yesterday along with CDC’s health alert for more details.

The Advisory Committee on Immunization Practices (ACIP) will be holding an emergency meeting today, April 14, 2021 from 1:30-4:30p.m. to further review these cases and assess their potential significance. You can find the draft meeting agenda here. Until this review process is complete and further guidance is provided, the CDC and FDA are recommending a pause in the use of this vaccine out of an abundance of caution. This pause will allow time to review data and help ensure the safety of the vaccine. 

 Please stay tuned as additional information regarding this topic will be forthcoming as we learn more on this.

Thank You,

-The Immunization Nurse Education Team, Andrea, Heidi, Maria, and Terri

• Joint CDC and FDA Statement on Johnson & Johnson COVID-19 Vaccine.pdf
• CDC-HAN-00442.pdf